In addition, MenaINV dramatically increases the sensitivity of receptor tyrosine kinases to their ligands EGF, IGF1 and HGF to increase cell protrusion and locomotion of tumor cells toward blood vessels9, 10, 49. Here, NTRK1 is linked to neoplasm.